GlaxoSmithKline Newsroom

Citi Sticks to Their Buy Rating for GlaxoSmithKline (GSK)

TipRanksJul 5 02:07 ET

UBS Sticks to Its Buy Rating for GlaxoSmithKline (GSK)

TipRanksJul 4 07:29 ET

GSK Analyst Ratings

BenzingaJul 2 13:59 ET

Jefferies Maintains Buy on GSK, Raises Price Target to $53

BenzingaJul 2 13:59 ET

J.P. Morgan Keeps Their Sell Rating on GlaxoSmithKline (GSK)

TipRanksJul 2 03:08 ET

GlaxoSmithKline (GSK) Gets a Hold From Goldman Sachs

TipRanksJul 1 09:34 ET

Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc

MT NewswiresJun 4 01:20 ET

GSK Analyst Ratings

BenzingaMay 30 06:47 ET

GlaxoSmithKline (GSK) Gets a Buy From Jefferies

TipRanksMay 13 08:36 ET

Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc

MT NewswiresMay 2 01:10 ET

Analysts Offer Insights on Healthcare Companies: Agilent (A), GlaxoSmithKline (GSK) and Stryker (SYK)

TipRanksApr 17 10:45 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: EBOS Group Limited (AU:EBO), Craneware (GB:CRW) and GlaxoSmithKline (GB:GSK)

TipRanksMar 5 04:11 ET

GSK Analyst Ratings

BenzingaMar 4 05:56 ET

Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc

MT NewswiresFeb 1 00:10 ET

GSK Analyst Ratings

BenzingaJan 23 06:44 ET

Jefferies Upgrades GSK to Buy, Raises Price Target to $48

BenzingaJan 3 05:46 ET

GSK Analyst Ratings

BenzingaJan 3 05:44 ET

Berenberg Bank Adjusts GSK Price Target to $41 From $44, Maintains Buy Rating

MT NewswiresNov 8, 2023 07:46 ET

Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc

MT NewswiresNov 2, 2023 02:20 ET

Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc

MT NewswiresOct 13, 2023 06:00 ET